National MS Society: Researchers Compare Outcomes When People 50 and Over Continue or Stop Their MS Therapies
March 28, 2024
March 28, 2024
NEW YORK, March 28 (TNSres) -- The National Multiple Sclerosis Society issued the following news:
Researchers consulted medical records from the French MS Registry to observe disease activity outcomes in people with MS who were 50 or older who had stopped taking highly effective* disease modifying therapies (DMTs) compared to matched individuals who continued on their highly effective therapies. They found that those on two particular therapies were more likely to experience new rel . . .
Researchers consulted medical records from the French MS Registry to observe disease activity outcomes in people with MS who were 50 or older who had stopped taking highly effective* disease modifying therapies (DMTs) compared to matched individuals who continued on their highly effective therapies. They found that those on two particular therapies were more likely to experience new rel . . .